Stratos Wealth Partners’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,657
Closed -$126K 1243
2022
Q2
$126K Sell
3,657
-162
-4% -$6.02K ﹤0.01% 1124
2022
Q1
$166K Sell
3,819
-410
-10% -$17.7K ﹤0.01% 1200
2021
Q4
$210K Sell
4,229
-501
-11% -$25.9K ﹤0.01% 1152
2021
Q3
$251K Buy
4,730
+161
+4% +$8.89K 0.01% 1008
2021
Q2
$265K Buy
4,569
+744
+19% +$42.3K 0.01% 1023
2021
Q1
$219K Buy
+3,825
New +$234K 0.01% 1005

Other funds holding HEAL

Stratos Wealth Partners's HEAL Position: Q3 2022 in Review

Stratos Wealth Partners sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q3 2022, closing a stake of 3,657 shares — an estimated $126K sold.

Stratos Wealth Partners first reported a position in HEAL in Q1 2021 and held it in 6 quarters. The position peaked at $265K in Q2 2021. 51 funds tracked by Wall St. Rank hold HEAL as of Q3 2022.

  • Stratos Wealth Partners reported no remaining Global X Funds Global X HealthTech ETF position as of Q3 2022 after selling out during the quarter.
  • Stratos Wealth Partners sold 3,657 Global X Funds Global X HealthTech ETF shares in Q3 2022, an estimated $126K.
  • Stratos Wealth Partners first reported a position in Global X Funds Global X HealthTech ETF in Q1 2021 and held it in 6 quarters.
  • Stratos Wealth Partners's Global X Funds Global X HealthTech ETF position peaked at $265K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q3 2022.

Based on Stratos Wealth Partners's 13F filing for Q3 2022, filed 24 Oct 2022.